Ozempic may soon be hard to find in Canada as supplier cites shortage


A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, the manufacturer said Friday.

Novo Nordisk said it is experiencing a temporary supply disruption with the Ozempic its one-millagram injection pen.

It said the shortage is due to a combination of global supply constraints and increased demand for the drug.

Health Canada said intermittent shortages are expected from late August to early October.

Both Health Canada and Novo Nordisk say the 0.25 mg and 0.5 mg doses of Ozempic remain available for patients with Type 2 diabetes.

They say pharmacists are encouraged to limit refill prescriptions to a 30-day supply.

More to come


More on Canada

&copy 2023 The Canadian Press

Products You May Like

Articles You May Like

Steve Harvey Realizes His Son Has Given Him a Gift He Didn’t Pay For – But That Wasn’t All, There Was More to Come
Man Realizes His 77-Year-Old Former Teacher Is Living in His Car – Gets Him Back on His Feet
Mom Finds Out Her Son Constantly Gets Into Trouble and Has Befriended the Bus Driver – So She Writes a Letter to the School Board
Meditation Simplified: How to Find Calm in Our Chaotic World
How I Calm My Anxiety Octopus at Home with My Aquaponics Zen Zone

Leave a Reply

Your email address will not be published. Required fields are marked *